Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (101-110 of 438) with videos related to

Pageof 44
Sort By:
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
Therapeutic Drug Monitoring|October 1, 2008
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patientsAntonio D'Avolio, Lorena Baietto, Marco Siccardi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 20, 2017
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective studyLucio Boglione, Chiara Simona Cardellino, Jessica Cusato, et al.
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Chemosusceptibility analysis of Plasmodium falciparum imported malaria in ItalyPietro Caramello, Francesca Canta, Ilaria Cavecchia, et al.
Scandinavian Journal of Infectious Diseases|October 18, 2013
Cerebrospinal fluid penetration of tigecyclineCarlo Pallotto, Maurizio Fiorio, Antonio D'Avolio, et al.
Therapeutic Drug Monitoring|December 31, 2009
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patientsAntonio D'Avolio, Marco Simiele, Lorena Baietto, et al.
European Addiction Research|August 13, 2018
Daclatasvir Plasma Levels in a Cohort of Patients with Hepatitis C Virus Infection Taking Methadone: A Prospective AnalysisLucio Boglione, Amedeo De Nicolò, Simone Mornese Pinna, et al.
HIV Clinical Trials|October 27, 2010
Impact of the background regimen on virologic response to etravirine: pooled 48-week analysis of DUET-1 and -2Benoit Trottier, Giovanni Di Perri, José Valdez Madruga, et al.
Le Infezioni in Medicina|June 26, 2015
Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?Francesco Giuseppe De Rosa, Silvia Corcione, Stefania Raviolo, et al.
Archives of Virology|January 11, 2018
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimensLucio Boglione, Jessica Cusato, Simone Mornese Pinna, et al.
Pageof 44

Showing results (101-110 of 438) with videos related to

Sort By:
Pageof 44
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
Therapeutic Drug Monitoring|October 1, 2008
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patientsAntonio D'Avolio, Lorena Baietto, Marco Siccardi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 20, 2017
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective studyLucio Boglione, Chiara Simona Cardellino, Jessica Cusato, et al.
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Chemosusceptibility analysis of Plasmodium falciparum imported malaria in ItalyPietro Caramello, Francesca Canta, Ilaria Cavecchia, et al.
Scandinavian Journal of Infectious Diseases|October 18, 2013
Cerebrospinal fluid penetration of tigecyclineCarlo Pallotto, Maurizio Fiorio, Antonio D'Avolio, et al.
Therapeutic Drug Monitoring|December 31, 2009
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patientsAntonio D'Avolio, Marco Simiele, Lorena Baietto, et al.
European Addiction Research|August 13, 2018
Daclatasvir Plasma Levels in a Cohort of Patients with Hepatitis C Virus Infection Taking Methadone: A Prospective AnalysisLucio Boglione, Amedeo De Nicolò, Simone Mornese Pinna, et al.
HIV Clinical Trials|October 27, 2010
Impact of the background regimen on virologic response to etravirine: pooled 48-week analysis of DUET-1 and -2Benoit Trottier, Giovanni Di Perri, José Valdez Madruga, et al.
Le Infezioni in Medicina|June 26, 2015
Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?Francesco Giuseppe De Rosa, Silvia Corcione, Stefania Raviolo, et al.
Archives of Virology|January 11, 2018
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimensLucio Boglione, Jessica Cusato, Simone Mornese Pinna, et al.
Pageof 44